Regenerx Biopharm In Analysis

Regenerx OTC Stock Analysis Notes

About 46.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Regenerx Biopharm had not issued any dividends in recent years. RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for Regenerx Biopharm In is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Regenerx Biopharm In contact J Finkelstein at 301 208 9191 or learn more at https://www.regenerx.com.

Regenerx Biopharm Investment Alerts

Regenerx Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regenerx Biopharm's market, we take the total number of its shares issued and multiply it by Regenerx Biopharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Regenerx Biopharm Outstanding Bonds

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Regenerx Biopharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Regenerx shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Regenerx Biopharm. By using and applying Regenerx OTC Stock analysis, traders can create a robust methodology for identifying Regenerx entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.